Medtech lobby seeks broader device eligibility for CMS’ proposed RAPID pathway

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 09 Oct, 15:26 UTC

AdvaMed called for more breakthrough devices, including diagnostics, to be eligible for the pathway, and for set timelines for national coverage determinations.

science

Sources

• T2Medtech lobby seeks broader device eligibility for CMS’ proposed RAPID pathwayBioPharma Dive / Healthcare Dive / MedTech Dive09 Oct, 15:26